مباشر

Clinical OMICsMayo Clinic’s REDMOD AI Doubles Early Detection Sensitivity in Pancreatic Cancer FierceBiotechIpsen scuttles liver disease candidates from $952M Albireo acquisition Endpoints NewsAmgen, AbbVie say IRA negotiations impacted Q1 sales Clinical OMICsAt-Home Blood Test Screens for Early Dementia Clinical OMICsGlioblastoma: Testosterone Supplements Linked to 38% Lower Risk of Death Endpoints NewsLilly plans new $4.5B manufacturing investment in Indiana Endpoints NewsBeOne culls five cancer programs and an autoimmune Phase 2 Endpoints NewsLonza looks to ride ADC wave with upcoming factory, workforce expansion FierceBiotechBipartisan PRIMATE Act aims to ban monkey imports to US Clinical OMICsEarly Glucagon Elevation Linked to MASLD in Type 2 Diabetes Clinical OMICsEpigenetic Markers Link Early-Onset Colon and Rectal Cancer to Specific Pesticide Clinical OMICsBlood Test Reads Cell Spatial Environment to Predict Immunotherapy Response

Clinical OMICs ٦ مايو ٢٠٢٦

Pancreatic Cancer Shares Genetic Drivers with Obesity and Diabetes

Six core genes have been found to be active in pancreatic cancer, obesity, and diabetes, providing an explanation to why metabolic disease is a major risk facto...

Six core genes have been found to be active in pancreatic cancer, obesity, and diabetes, providing an explanation to why metabolic disease is a major risk factor for pancreatic cancer. The post Pancreatic Cancer Shares Genetic Drivers with Obesity and Diabetes appeared first on Inside Precision Medicine .